1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL SURGICAL ROBOTS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED

2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING AGEING POPULATION
3.1.2. RISING CASE OF ACUTE AND CHRONIC DISEASES
3.1.3. BETTER BENEFITS TO PATIENTS AND SURGEONS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO
3.2.2. SHORTAGE OF TRAINED SURGEONS
3.2.3. HIGH COST OF THE EQUIPMENT AND SURGERY
3.3. OPPORTUNITIES
3.3.1. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.3.2. INCREASING NEED OF REDUCING HEALTHCARE COSTS IN U.S
3.4. CHALLENGES
3.4.1. INCREASING COMPETITORS
3.4.2. HIGH ENTRY LEVEL COSTS
3.4.3. HIGH LEVEL ENTRY BARRIERS DUE TO PATENTS

4. PREMIUM INSIGHTS

5. REPORT DESCRIPTION

6. GLOBAL SURGICAL ROBOTS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. SYSTEMS
6.3. INSTRUMENTS
6.4. ACCESSORIES AND SERVICES

7. GLOBAL SURGICAL ROBOTS MARKET, BY BRANDS
7.1. OVERVIEW
7.2. DA VINCI SURGICAL SYSTEM
7.3. CYBERKNIFE
7.4. RENAISSANCE
7.5. ARTAS
7.6. ROSA

8. GLOBAL SURGICAL ROBOTS MARKET, BY APPLICATION
8.1. INTRODUCTION
8.2. GENERAL SURGERY
8.3. UROLOGICAL SURGERY
8.4. GYNECOLOGICAL SURGERY
8.5. GASTROINTESTINAL SURGERY
8.6. RADICAL PROSTATECTOMY
8.7. CARDIOTHORACIC SURGERY
8.8. COLORECTAL SURGERY
8.9. RADIOTHERAPY
8.10. OTHERS

9. GLOBAL SURGICAL ROBOTS MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. NORTH AMERICA SURGICAL ROBOTS MARKET
9.2.1. U.S. SURGICAL ROBOTS MARKET
9.2.2. CANADA SURGICAL ROBOTS MARKET
9.2.3. MEXICO SURGICAL ROBOTS MARKET
9.3. EUROPE SURGICAL ROBOTS MARKET
9.3.1. GERMANY SURGICAL ROBOTS MARKET
9.3.2. FRANCE SURGICAL ROBOTS MARKET
9.3.3. U.K. SURGICAL ROBOTS MARKET
9.3.4. ITALY SURGICAL ROBOTS MARKET
9.3.5. SPAIN SURGICAL ROBOTS MARKET
9.3.6. SWITZERLAND SURGICAL ROBOTS MARKET
9.3.7. NETHERLANDS SURGICAL ROBOTS MARKET
9.3.8. RUSSIA SURGICAL ROBOTS MARKET
9.3.9. BELGIUM SURGICAL ROBOTS MARKET
9.3.10. TURKEY SURGICAL ROBOTS MARKET
9.3.11. REST OF EUROPE SURGICAL ROBOTS MARKET
9.4. APAC SURGICAL ROBOTS MARKET
9.4.1. JAPAN SURGICAL ROBOTS MARKET
9.4.2. CHINA SURGICAL ROBOTS MARKET
9.4.3. SOUTH KOREA SURGICAL ROBOTS MARKET
9.4.4. INDIA SURGICAL ROBOTS MARKET
9.4.5. AUSTRALIA SURGICAL ROBOTS MARKET
9.4.6. THAILAND SURGICAL ROBOTS MARKET
9.4.7. SINGAPORE SURGICAL ROBOTS MARKET
9.4.8. MALAYSIA SURGICAL ROBOTS MARKET
9.4.9. PHILIPPINES SURGICAL ROBOTS MARKET
9.4.10. INDONESIA SURGICAL ROBOTS MARKET
9.4.11. REST OF APAC SURGICAL ROBOTS MARKET
9.5. SOUTH AMERICA SURGICAL ROBOTS MARKET
9.5.1. BRAZIL SURGICAL ROBOTS MARKET
9.5.2. REST OF SOUTH AMERICA SURGICAL ROBOTS MARKET
9.6. MEA SURGICAL ROBOTS MARKET
9.6.1. SOUTH AFRICA SURGICAL ROBOTS MARKET
9.6.2. REST OF MEA SURGICAL ROBOTS MARKET

10. GLOBAL SURGICAL ROBOTS MARKET, COMPANY LANDSCAPE
10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC
10.5. RECENT DEVELOPMENT BY COMPANY: GLOBAL
10.6. APPROVALS BY COMPANY: GLOBAL
10.7. RECENT DEVELOPMENTS BY TYPE: GLOBAL

11. COMPANY PROFILES
11.1. INTUITIVE SURGICAL, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.1.2.1. DRIVERS EXPLAINED
11.1.2.2. WEAKNESSES EXPLAINED
11.1.2.3. OPPORTUNITIES EXPLAINED
11.1.2.4. THREATS EXPLAINED
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPMENTS
11.2. MAZOR ROBOTICS
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.2.2.1. DRIVERS EXPLAINED
11.2.2.2. WEAKNESSES EXPLAINED
11.2.2.3. OPPORTUNITIES EXPLAINED
11.2.2.4. THREATS EXPLAINED
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT DEVELOPMENTS
11.3. ACCURAY, INC.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.3.2.1. DRIVERS EXPLAINED
11.3.2.2. WEAKNESSES EXPLAINED
11.3.2.3. OPPORTUNITIES EXPLAINED
11.3.2.4. THREATS EXPLAINED
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPMENTS
11.4. STRYKER CORPORATION
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.4.2.1. DRIVERS EXPLAINED
11.4.2.2. WEAKNESSES EXPLAINED
11.4.2.3. OPPORTUNITIES EXPLAINED
11.4.2.4. THREATS EXPLAINED
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPMENTS
11.5. MEDTECH S.A.(A ZIMMER BIOMET COMPANY)
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.5.2.1. DRIVERS EXPLAINED
11.5.2.2. WEAKNESSES EXPLAINED
11.5.2.3. OPPORTUNITIES EXPLAINED
11.5.2.4. THREATS EXPLAINED
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT DEVELOPMENTS
11.6. VERB SURGICAL INC.,
11.6.1. COMPANY OVERVIEW
11.6.2. REVENUE ANALYSIS
11.6.3. PRODUCT PIPELNE
11.6.4. RECENT DEVELOPMENTS
11.7. AURIS SURGICAL ROBOTICS
11.7.1. COMPANY OVERVIEW
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. RECENT DEVELOPMENTS
11.8. RESTORATION ROBOTICS, INC
11.8.1. COMPANY OVERVIEW
11.8.2. REVENUE ANALYSIS
11.8.3. PRODUCT PORTFOLIO
11.8.4. RECENT DEVELOPMENTS
11.9. VIRTUAL INCISION CORPORATION
11.9.1. COMPANY OVERVIEW
11.9.2. REVENUE ANALYSIS
11.9.3. PRODUCT PIPELINE
11.9.4. RECENT DEVELOPMENTS
11.10. TITAN MEDICAL INC
11.10.1. COMPANY OVERVIEW
11.10.2. REVENUE ANALYSIS
11.10.3. PRODUCT PIPELINE
11.10.4. RECENT DEVELOPMENTS
11.11. HOCOMA
11.11.1. COMPANY OVERVIEW
11.11.2. REVENUE ANALYSIS
11.11.3. PRODUCT PORTFOLIO
11.11.4. RECENT DEVELOPMENTS
11.12. MEDROBOTICS CORPORATION
11.12.1. COMPANY OVERVIEW
11.12.2. REVENUE ANALYSIS
11.12.3. PRODUCT PORTFOLIO
11.12.4. RECENT DEVELOPMENTS

12. RELATED REPORTS